Prot #STU00222155: Rapid Onsite Cytopathologic Evaluation for Improved Molecular Marker Testing via Endobronchial Ultrasound Bronchoscopy - A Randomized Controlled Trial

Project: Research project

Project Details

StatusActive
Effective start/end date5/1/244/30/26

Funding

  • Johns Hopkins University (Prot #STU00222155 // Prot #STU00222155)
  • AstraZeneca Pharmaceuticals LP (Prot #STU00222155 // Prot #STU00222155)